2024. Induced Pluripotent Stem Cells and CRISPR-Cas9 Gene-Editing on Transthyretin Amyloid Cardiomyopathy. Global Journal of Science Frontier Research. 24, G1 (Nov. 2024), 1–3. DOI:https://doi.org/10.34257/GJSFRGVOL24IS1PG1.